Recombinant Proteins Manufacturing Services Market in United States, United Kingdom – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

Recombinant Proteins Manufacturing Services Market – Report Overview

Pacific Business Consulting’s “Recombinant Proteins Manufacturing Services Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Recombinant Proteins Manufacturing Services market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

In 2022, the Recombinant Proteins Manufacturing Services market exceeded a valuation of over US$ 1.6 Billion, and it is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) exceeding 8.0% from 2023 to 2030. The market is expected to potentially surpass US$ 3.0 Billion by 2030.

The recombinant antibody production process involves cloning antibody gene libraries into phage vectors and expressing the recombinant antibodies on the surfaces of phages, which are then used to infect host cell lines. This method enables the large-scale production of antibodies with desired characteristics. The growth of this segment is expected to be driven by factors such as increasing cases of leukemia, along with the growth of research and clinical studies.

Protein production, especially recombinant proteins, is a complex and cost-intensive process that demands specialized facilities and large-scale production capabilities. Challenges related to regulatory compliance and adherence to manufacturing standards have led to a growing trend of outsourcing recombinant protein production to Contract Manufacturing Organizations (CMOs). Outsourcing certain specialized and repetitive activities, such as fill/finish, analytical testing/bioassays, and toxicology testing, has become more common in the biopharmaceutical industry.

The use of recombinant proteins is crucial in the development of innovative therapeutics for various chronic conditions, including cancer and rare disorders. The demand for advanced protein production platforms has increased, as many applications require the manufacturing of complex proteins and glycoproteins. The rising cases of diabetes and the increasing use of antibodies are contributing to the growth of this segment, as seen in the global increase in diabetes cases reported by the International Diabetes Federation (IDF) in 2021.

Mergers, acquisitions, partnerships, and new product launches by key market players are also significant drivers of growth in the recombinant protein market. For instance, the collaboration between Sanofi and GSK in 2021 for the development of a recombinant protein COVID-19 vaccine candidate demonstrates the industry’s commitment to advancing innovative solutions.

While the recombinant protein market is expected to experience significant growth due to factors such as increased research and development expenditure, the rising prevalence of chronic diseases, and the launch of advanced recombinant products, challenges such as time-consuming and high-cost production processes may pose obstacles to market growth over the forecast period.

Leading players in the Recombinant Proteins Manufacturing Services segment, including GenScript, Kaneka Corporation (Kaneka Eurogentec S.A), Polyplus Transfection (Xpress Biologics), Boster Biological Technology, Trenzyme GmbH, Lonza, Boehringer Ingelheim International GmbH, FUJIFILM, Diosynth Biotechnologies, Merck KGaA, Bruker (InVivo BioTech Services GmbH) and Sino Biological, Inc., are expected to play a crucial role in shaping the future landscape of Recombinant Proteins Manufacturing Services technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Recombinant Proteins Manufacturing Services market. It also delves into the analysis of present and prospective market competition within the global Recombinant Proteins Manufacturing Services market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Recombinant Proteins Manufacturing Services market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Recombinant Proteins Manufacturing Services market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

1. Executive Summary: Recombinant Proteins Manufacturing Services
   • Global Market Outlook: Recombinant Proteins Manufacturing Services
2. Competitive Intelligence Analysis: Recombinant Proteins Manufacturing Services
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Recombinant Proteins Manufacturing Services
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: Recombinant Proteins Manufacturing Services
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. Recombinant Proteins Manufacturing Services: Ten Major Market (10MM) – Market Analysis, By Services Type
   • Pre-clinical & Clinical Services
   • Commercial Production Services
9. Recombinant Proteins Manufacturing Services: Ten Major Market (10MM) – Market Analysis, By Host Cell Type
   • Mammalian Cells
   • Insect Cells
   • Bacterial Cells
   • Yeast & Fungi
   • Others
10. Recombinant Proteins Manufacturing Services: Ten Major Market (10MM) – Market Analysis, By End User
    • Academic & Research Centers
    • Pharmaceutical & Biotechnology Companies
    • Other End Users
11. Recombinant Proteins Manufacturing Services: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Services Type
      • By Host Cell Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Services Type
      • By Host Cell Type
      • By End User

12. S. Recombinant Proteins Manufacturing Services – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Services Type
      • By Host Cell Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Services Type
      • By Host Cell Type
      • By End User

13. K. Recombinant Proteins Manufacturing Services – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Services Type
      • By Host Cell Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Services Type
      • By Host Cell Type
      • By End User

14. Germany Recombinant Proteins Manufacturing Services – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Services Type
      • By Host Cell Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Services Type
      • By Host Cell Type
      • By End User

15. France Recombinant Proteins Manufacturing Services – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Services Type
      • By Host Cell Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Services Type
      • By Host Cell Type
      • By End User

16. Italy Recombinant Proteins Manufacturing Services – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Services Type
      • By Host Cell Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Services Type
      • By Host Cell Type
      • By End User

17. Spain Recombinant Proteins Manufacturing Services – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Services Type
      • By Host Cell Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Services Type
      • By Host Cell Type
      • By End User

18. Japan Recombinant Proteins Manufacturing Services – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Services Type
      • By Host Cell Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Services Type
      • By Host Cell Type
      • By End User

19. China Recombinant Proteins Manufacturing Services – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Services Type
      • By Host Cell Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Services Type
      • By Host Cell Type
      • By End User

20. Australia Recombinant Proteins Manufacturing Services – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Services Type
      • By Host Cell Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Services Type
      • By Host Cell Type
      • By End User

21. India Recombinant Proteins Manufacturing Services – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Services Type
      • By Host Cell Type
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Services Type
      • By Host Cell Type
      • By End User

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer